GZR4 Injection vs Insulin Degludec
- For adults aged 18-75 years old
- Diagnosed with T2DM for at least 6 months
- Sponsored by Gan and Lee Pharmaceuticals
Phase 2 Clinical Study • Enrolling Now
Explore a New Approach to Type 2 Diabetes Management
Join a clinical research study evaluating the safety and efficacy of a once-weekly injection compared to daily insulin for adults with Type 2 Diabetes.
Monitored Safety
Expert Care Team
Trusted by Participants
About the Study
Sponsored by Gan and Lee Pharmaceuticals, USA
This clinical trial evaluates the efficacy, safety, and tolerability of once-weekly GZR4 Injection compared to once-daily insulin degludec. It is designed for patients with type 2 diabetes mellitus (T2DM) whose condition is inadequately controlled on oral antidiabetic drug (OAD) therapy, or OAD therapy combined with basal insulin.
What to Expect
- Initial Screening
Our clinical team will review your medical history and current HbA1c levels to ensure this study is a safe fit for you.
- Study Treatment Assignment
Participants will be randomized to receive either the investigational once-weekly injection or the standard once-daily insulin.
- Ongoing Health Monitoring
Receive regular check-ups, blood glucose monitoring, and dedicated medical care throughout the trial duration at no cost.
Criteria
Who can participate?
Review the guidelines below to see if this Type 2 Diabetes study might be a good fit for your health journey.
You May Qualify If...
- You are between 18 and 75 years of age.
- Your Body Mass Index (BMI) is between 18.5 and 35.0.
- You have been diagnosed with Type 2 Diabetes for at least 6 months.
- Your HbA1c level is currently between 7.5% and 10.0%.
You May Not Qualify If...
- You are currently pregnant or breast-feeding.
- You have a history of cancer.
- You have had severe diabetes complications or severe low blood sugar in the last 6 months.
- You have had a heart attack, stroke, or acute heart failure in the last 6 months.
- You have participated in another clinical trial within the last 3 months.
Not sure if you qualify?
Take our quick eligibility quiz to find out if you can move forward.
Check your eligibility
Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. If you have the common symptoms, you may be eligible to take part in the study.
Study Benefits & Care
By participating in this type 2 diabetes research study, you will receive all study-related care and monitoring at no cost to you or your insurance.
Study Medication
Receive the investigational GZR4 injection or the standard once-daily insulin degludec at no cost during your trial participation.
Health Monitoring
Undergo regular health check-ups, medical exams, and comprehensive diabetes monitoring throughout the duration of the study.
Specialist Care
Gain direct access to a dedicated team of study doctors and medical professionals who specialize in type 2 diabetes management.
Medical Research
Play a vital role in advancing medical science and helping evaluate potential new treatment options for patients with type 2 diabetes.
Study Sponsored By
Gan and Lee Pharmaceuticals, USA
Frequently Asked Questions
We understand you may have questions about participating in the GZR4 Injection study. We are committed to providing clear, transparent answers to help you make an informed decision.
What is a clinical trial and is it safe?
A clinical trial is a carefully designed research study that explores whether a medical strategy or treatment is safe and effective. Safety is our highest priority. This study follows strict scientific protocols approved by an independent review board, and your health will be closely monitored by dedicated medical professionals throughout your participation.
How long will I be in the study?
The exact duration depends on the specific study phases, which typically include a screening period, a treatment period, and follow-up visits. Our study team will provide you with a comprehensive timeline and schedule during your initial consultation, before you agree to participate.
What are the possible risks and side effects?
As with any medical treatment, there may be risks. Potential side effects of the investigational medication (GZR4 Injection) or the comparator (Insulin Degludec) will be thoroughly explained to you in the Informed Consent Form. You will have ample time to discuss these with the study doctor before deciding to join.
Will my information be kept confidential?
Yes, your privacy is strictly protected by law. Any medical data collected during the study is anonymized, meaning your personal identifying information (like your name and address) is removed before it is shared with researchers, the sponsor (Gan and Lee Pharmaceuticals), or regulatory agencies.
Can I leave the study if I change my mind?
Absolutely. Your participation is entirely voluntary. You have the right to withdraw from the study at any time, for any reason, without any penalty or loss of benefits to your standard medical care.
Will I receive the actual medication or a placebo?
This specific study compares GZR4 Injection to Insulin Degludec. There is no placebo group in this trial; all participants will receive an active medication to help manage their Type 2 Diabetes. The study team will explain the randomization process during your screening visit.
What happens after the study ends?
Once your participation concludes, you will return to the care of your regular primary care physician or endocrinologist. The study team will discuss any necessary follow-up care and provide information on how you can access the overall results of the research once they are published.